← All Sponsors
SPONSOR

Immunovant Sciences GmbH

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Primary Sjögren's Syndrome
NCT06979531 Phase 2
Recruiting

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

Primary Sjögren's Syndrome
United States, Argentina, Brazil View Trial →